Cite
HARVARD Citation
Palumbo, M. et al. (2022). Inhibition of PCSK9 affects serum lipoprotein functions in patients with familial hypercholesterolemia. Atherosclerosis. pp. 75-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Palumbo, M. et al. (2022). Inhibition of PCSK9 affects serum lipoprotein functions in patients with familial hypercholesterolemia. Atherosclerosis. pp. 75-. [Online].